Shopping Cart
- Remove All
- Your shopping cart is currently empty
Libivirumab (17.1.41), a humanized monoclonal antibody targeting hepatitis B virus (HBV), demonstrates neutralizing activity with half maximal inhibitory concentrations (IC50) of 35 ng/mL for HBsAg and 130 ng/mL for HBeAg, respectively [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $247 | 2-4 weeks | |
5 mg | $647 | 2-4 weeks | |
10 mg | $987 | 2-4 weeks |
Description | Libivirumab (17.1.41), a humanized monoclonal antibody targeting hepatitis B virus (HBV), demonstrates neutralizing activity with half maximal inhibitory concentrations (IC50) of 35 ng/mL for HBsAg and 130 ng/mL for HBeAg, respectively [1]. |
Cas No. | 569658-79-3 |
Storage | store at -80°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.